CEREBROLYSIN
Compound Overview
Cerebrolysin is a standardized peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids produced through the enzymatic hydrolysis of purified porcine brain proteins. The preparation contains a complex mixture of biologically active peptide fragments, many of which are sufficiently small to cross the blood-brain barrier under experimental conditions, making Cerebrolysin an important investigational compound in neuroscience research.
Researchers have extensively investigated Cerebrolysin for its interactions with neuronal signaling pathways, neurotrophic mechanisms, synaptic physiology, neuroplasticity, cellular metabolism, and molecular responses to neuronal injury. Experimental studies have examined its influence on neurotrophic factor-associated pathways, neuronal survival mechanisms, protein synthesis, mitochondrial function, and cellular communication within the central nervous system.
As an investigational peptide preparation, Cerebrolysin supports laboratory research involving neuroscience, neurobiology, molecular signaling, peptide pharmacology, and structure-function relationships in controlled experimental models.
Research Applications
Research applications are presented for educational and informational purposes only and do not imply approved therapeutic uses.
Product Specifications
| Purity | Standardized Peptide Preparation |
| Appearance | Clear, Colorless to Light Amber Sterile Solution |
| Composition | Low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins |
| Average Molecular Weight | Predominantly peptides <10 kDa |
| CAS Number | 12656-61-0 |
| Storage | Store refrigerated at 2–8°C (36–46°F). Protect from light. Do not freeze unless specified by validated laboratory protocols. |
| Research Grade | Laboratory Research Use Only |
Available Sizes
Pricing: Inquire — contact our team for current pricing and availability.
Product Documentation
Every batch of CEREBROLYSIN is independently tested and assigned its own lot number. When you request documentation, include the product name and lot number printed on your vial so we can send the COA, HPLC, and MS data specific to the batch in your hand — not a generic reference sample. Request documentation →
Laboratory Handling
Store refrigerated immediately upon receipt to preserve peptide integrity and biological activity. Protect the solution from direct light and excessive heat. Avoid repeated freeze-thaw cycles and unnecessary agitation, as these may affect the stability of the peptide components. Handle using sterile laboratory equipment and appropriate aseptic techniques. This product is intended solely for qualified research personnel conducting controlled laboratory investigations.
Selected Scientific Literature
- Alvarez XA, Cacabelos R, Sampedro C, et al. Combination Treatment in Alzheimer's Disease: Cerebrolysin and Donepezil. Journal of Neural Transmission.
- Rockenstein E, Mante M, Adame A, et al. Effects of Cerebrolysin on Neurogenesis in Experimental Models of Neurodegeneration. Acta Neuropathologica.
- Gauthier S, Proaño JV, Jia J, et al. Cerebrolysin in Neurological Research: Mechanisms and Clinical Evidence. Journal of Neural Transmission.
- Masliah E, Diez-Tejedor E. Neurotrophic Peptide Preparations and Their Role in Experimental Neuroscience. CNS Neuroscience & Therapeutics.
Compare with related compounds
Other compounds researchers commonly browse alongside CEREBROLYSIN in Cognitive & Neuro.
| Compound | Purity | Molecular Weight | CAS Number |
|---|---|---|---|
| CEREBROLYSIN | Standardized Peptide Preparation | — | 12656-61-0 |
| DSIP (DELTA SLEEP-INDUCING PEPTIDE) | 99% | 848.81 g/mol | 62568-57-4 |
| SELANK | 99% | 751.87 g/mol | 129954-34-3 |
| SEMAX | 99% | 813.87 g/mol | 80714-61-0 |
| PINEALON | 99% | 418.40 g/mol | Not Assigned |
Need a Certificate of Analysis?
Request COAs, HPLC, or MS documentation for CEREBROLYSIN.